Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -173,599 | -81,387 | -341,973 | -258,478 | -192,744 |
| Depreciation Amortization | -4,193 | -2,270 | -5,494 | -3,200 | -1,687 |
| Accounts receivable | N/A | N/A | 306 | 95 | 228 |
| Accounts payable and accrued liabilities | 16,418 | N/A | N/A | 2,980 | 4,202 |
| Other Working Capital | 20,822 | 7,978 | -32,458 | -11,859 | 16,926 |
| Other Operating Activity | 24,396 | 25,356 | 79,303 | 59,334 | 37,344 |
| Operating Cash Flow | $-116,156 | $-50,323 | $-300,316 | $-211,128 | $-135,731 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 368,290 | 203,095 | 647,302 | 450,691 | 293,984 |
| PPE Investments | -1,791 | -1,780 | -4,126 | -4,008 | -3,418 |
| Purchase Of Investment | -310,418 | -190,784 | -385,542 | -248,727 | -163,975 |
| Investing Cash Flow | $56,081 | $10,531 | $257,634 | $197,956 | $126,591 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 50,464 | 48,922 | 34,753 | 12,835 | 3,377 |
| Financing Cash Flow | $50,464 | $48,922 | $34,753 | $12,835 | $3,377 |
| Beginning Cash Position | 146,443 | 146,443 | 154,372 | 154,372 | 154,372 |
| End Cash Position | 136,832 | 155,573 | 146,443 | 154,035 | 148,609 |
| Net Cash Flow | $-9,611 | $9,130 | $-7,929 | $-337 | $-5,763 |
| Free Cash Flow | |||||
| Operating Cash Flow | -116,156 | -50,323 | -300,316 | -211,128 | -135,731 |
| Capital Expenditure | -1,791 | -1,780 | -4,126 | -4,008 | -3,418 |
| Free Cash Flow | -117,947 | -52,103 | -304,442 | -215,136 | -139,149 |